Press Releases | Association for Accessible Medicines

Pill Bottles

Dec 13, 2018 | Rachel Schwartz

AAM Statement on FDA Withdrawal of Generic Drug Labeling Rule

Dec 10, 2018 | Rachel Schwartz

Andrew O’Connor Joins AAM as Manager, State Government Affairs

AAM Statement on Signing of USMCA by President

Nov 30, 2018 | Rachel Schwartz

AAM Statement on Signing of USMCA by President

Preserve Patient Access in USMCA

Nov 14, 2018 | Rachel Schwartz

Poll Results: Americans’ Attitudes on U.S. Trade Policy and Drug Pricing

Patient Groups, Retirees, American Workers, Doctors, Manufacturers, Join to Voice Concern Over Proposed Trade Deal

Nov 5, 2018 | Rachel Schwartz

Patient Groups, Retirees, American Workers, Doctors, Manufacturers, Join to Voice Concern Over Proposed Trade Deal

Supreme Court

Oct 17, 2018 | Rachel Schwartz

AAM Files Amicus Brief in Helsinn v Teva

Applauding Nomination of Dr. Scott Gottlieb to Lead the FDA

Oct 11, 2018 | Rachel Schwartz

AAM Statement on FDA Record Generic Approvals

New NAFTA - Proposed US-Mexico-Canada Agreement (USMCA)

Oct 1, 2018 | Rachel Schwartz

AAM Opposes Barriers to Generic Drug and Biosimilar Access in Proposed US-Mexico-Canada Agreement (USMCA)

Sep 24, 2018 | Rachel Schwartz

Dana Mariani Joins AAM as Director, Policy

Sep 20, 2018 | Rachel Schwartz

AAM Statement on CBO CREATES Score

Sep 4, 2018 | Rachel Schwartz

New Study Finds Patients, Government and Insurance Lose $13.4B in Potential Savings By Brand Drug Companies’ Abuses

New NAFTA - North American Generic Drugmakers Call for Rejection of New Exclusivity Period for Biologics

Aug 28, 2018 | Rachel Schwartz

North American Generic Drugmakers Call for Rejection of New Exclusivity Period for Biologics